EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC-ND 4.0

Comparison of demographic, clinical and follow-up data of patients with micromegaly and acromegaly: a retrospective analysis from a single tertiary center

Canan Sehit Kara, Gokcem Yalin Kocamaz, İzzet Okcesiz, Emre Urhan, Aysa Hacioglu, Zuleyha Karaca, Kursad Unluhizarci

BMC Endocrine Disorders · 2026

DOI: 10.1186/s12902-026-02444-2 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift BMC Endocrine Disorders, 2026. Verfasst von Canan Sehit Kara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Erciyes University Medical School, Kayseri, Turkey. Hauptthemen laut MEDLINE: Acromegaly, Adenoma, Pituitary Neoplasms. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Micromegaly is a term suggested to describe patients with clinical and biochemical evidence of acromegaly despite apparently normal GH secretion. However, its clinical characteristics including biochemical definition, treatment outcomes, and long-term prognosis remain incompletely understood. This study aimed to determine the prevalence of micromegaly and compare the demographic, clinical, biochemical, radiological, and long-term follow-up characteristics of patients with micromegaly and classical acromegaly. METHODS: A retrospective chart review was conducted in patients with acromegaly, who were diagnosed and subsequently followed up in Erciyes University Department of Endocrinology between January 2010 and September 2025. Micromegaly was defined on the basis of the finding of a baseline growth hormone (GH) < 2 ng/mL and/or glucose-suppressed GH nadir < 1 ng/mL, in addition to an IGF-1 level above the upper limit of normal in a patient with the classic symptoms and signs of the disease. RESULTS: Among 117 patients with acromegaly, 14 (12%) were classified as having micromegaly. No statistically significant differences were observed in the age at diagnosis, gender distribution, comorbidities and clinical symptoms between patients with acromegaly and micromegaly. The micromegaly group demonstrated a higher incidence of microadenoma, with a significantly smaller maximal tumor size compared to the acromegaly group. The rate of surgical intervention, the total number of operations, and the rate of additional medical treatment among patients with acromegaly were significantly higher than among patients with micromegaly. The biochemical control rate observed at 3 months postoperatively was higher in the micromegaly group, while the remission rate at the last visit was similar between the two groups. CONCLUSION: Patients classified as having micromegaly according to the biochemical criteria applied in this study exhibited clinical manifestations and comorbidity profiles comparable to those of patients with classical acromegaly despite lower GH levels and smaller tumors. Sensitivity analyses using alternative biochemical definitions demonstrated a broadly consistent overall clinical pattern across the different classification approaches. These findings suggest that apparently low GH secretion does not necessarily indicate clinically mild disease. Prospective multicentre studies using standardized biochemical definitions are required to further clarify the biological basis and clinical significance of micromegaly. CLINICAL TRIAL NUMBER: Not applicable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyAdenomaPituitary NeoplasmsHumansFemaleRetrospective StudiesMaleFollow-Up StudiesMiddle AgedAdultPrognosisHuman Growth HormoneTertiary Care CentersInsulin-Like Growth Factor IAged

Stichwörter der Autor:innen

AcromegalyGrowth hormoneInsulin-like growth factorMicromegalyPituitary adenoma

Substanzen

Human Growth HormoneInsulin-Like Growth Factor I

Autor:innen und Institutionen

  • Department of Endocrinology, Erciyes University Medical School, Kayseri, Turkey.
  • Department of Radiology, Erciyes University Medical School, Kayseri, Turkey.
  • Department of Endocrinology, Erciyes University Medical School, Kayseri, Turkey. zuleyha@erciyes.edu.tr.

Zitieren

APA

Sehit Kara, C., Yalin Kocamaz, G., Okcesiz, İ., Urhan, E., Hacioglu, A., Karaca, Z., & Unluhizarci, K. (2026). Comparison of demographic, clinical and follow-up data of patients with micromegaly and acromegaly: a retrospective analysis from a single tertiary center. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02444-2

Vancouver

Sehit Kara C, Yalin Kocamaz G, Okcesiz İ, Urhan E, Hacioglu A, Karaca Z, et al. Comparison of demographic, clinical and follow-up data of patients with micromegaly and acromegaly: a retrospective analysis from a single tertiary center. BMC Endocrine Disorders. 2026. doi:10.1186/s12902-026-02444-2

BibTeX
@article{SehitKara2026,
  author = {Sehit Kara, Canan and Yalin Kocamaz, Gokcem and Okcesiz, İzzet and Urhan, Emre and Hacioglu, Aysa and Karaca, Zuleyha and Unluhizarci, Kursad},
  title = {Comparison of demographic, clinical and follow-up data of patients with micromegaly and acromegaly: a retrospective analysis from a single tertiary center},
  journal = {BMC Endocrine Disorders},
  year = {2026},
  doi = {10.1186/s12902-026-02444-2}
}
Kostenlos starten →